Innate Pharma (IPH) — Tangible Net Worth Ratio
Innate Pharma (IPH) has a Tangible Net Worth Ratio of 100.0% as of June 2025. This metric is calculated by deducting intangible assets (€0.00) from net assets (€5.14 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Innate Pharma equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Innate Pharma Tangible Net Worth Ratio (2003–2024)
This chart shows how Innate Pharma's Tangible Net Worth Ratio has changed across 22 annual periods from 2003 to 2024. As of June 2025, the ratio stands at 100.0%, reflecting net assets of €5.14 Million with intangible assets of €0.00 EUR. For live market cap and overall valuation, see Innate Pharma market cap and net worth.
Annual Tangible Net Worth Ratio for Innate Pharma (2003–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Innate Pharma from 2003 to 2024, covering 22 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Innate Pharma capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | €8.83 Million | €0.00 | €111.06 Million | ▲ +0.8 pp |
| 2023 | 99.2% | €51.90 Million | €416.00K | €184.19 Million | ▲ +77.8 pp |
| 2022 | 21.4% | €54.15 Million | €42.55 Million | €207.86 Million | ▼ -37.5 pp |
| 2021 | 58.9% | €107.44 Million | €44.19 Million | €267.50 Million | ▼ -11.5 pp |
| 2020 | 70.3% | €155.97 Million | €46.29 Million | €307.42 Million | ▲ +14.9 pp |
| 2019 | 55.4% | €217.42 Million | €96.97 Million | €401.36 Million | ▲ +5.9 pp |
| 2018 | 49.5% | €167.24 Million | €84.53 Million | €451.22 Million | ▲ +3.2 pp |
| 2017 | 46.3% | €85.96 Million | €46.19 Million | €255.02 Million | ▼ -43.2 pp |
| 2016 | 89.5% | €86.17 Million | €9.07 Million | €281.58 Million | ▲ +3.0 pp |
| 2015 | 86.5% | €72.07 Million | €9.73 Million | €305.96 Million | ▼ -6.3 pp |
| 2014 | 92.8% | €74.63 Million | €5.36 Million | €90.69 Million | ▼ -7.2 pp |
| 2013 | 100.0% | €40.29 Million | €0.00 | €55.88 Million | ▲ +0.0 pp |
| 2012 | 100.0% | €23.36 Million | €0.00 | €48.30 Million | ▲ +0.0 pp |
| 2011 | 100.0% | €26.62 Million | €0.00 | €60.11 Million | ▲ +0.0 pp |
| 2010 | 100.0% | €33.52 Million | €0.00 | €48.01 Million | ▲ +0.0 pp |
| 2009 | 100.0% | €47.12 Million | €0.00 | €64.22 Million | ▲ +0.0 pp |
| 2008 | 100.0% | €41.34 Million | €0.00 | €60.86 Million | ▲ +0.0 pp |
| 2007 | 100.0% | €49.61 Million | €0.00 | €63.15 Million | ▲ +0.0 pp |
| 2006 | 100.0% | €56.37 Million | €0.00 | €69.25 Million | ▲ +0.2 pp |
| 2005 | 99.8% | €20.07 Million | €34.00K | €24.77 Million | ▲ +1.4 pp |
| 2004 | 98.4% | €25.01 Million | €392.00K | €29.51 Million | ▲ +0.8 pp |
| 2003 | 97.6% | €15.11 Million | €361.00K | €20.38 Million | — |